Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes (Q37586729)
Jump to navigation
Jump to search
scientific article published on 13 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes |
scientific article published on 13 January 2017 |
Statements
1 reference
Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes (English)
1 reference
Javad Habibi
Annayya R Aroor
James R Sowers
Guanghong Jia
Melvin R Hayden
Mona Garro
Brady Barron
Eric Mayoux
R Scott Rector
Adam Whaley-Connell
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference